Cargando…
Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
Accumulating evidence indicates that obesity is closely associated with an increased risk of metabolic diseases such as insulin resistance, type 2 diabetes, dyslipidemia and nonalcoholic fatty liver disease. Obesity results from an imbalance between food intake and energy expenditure, which leads to...
Autores principales: | Jung, Un Ju, Choi, Myung-Sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013623/ https://www.ncbi.nlm.nih.gov/pubmed/24733068 http://dx.doi.org/10.3390/ijms15046184 |
Ejemplares similares
-
Apigenin Ameliorates Dyslipidemia, Hepatic Steatosis and Insulin Resistance by Modulating Metabolic and Transcriptional Profiles in the Liver of High-Fat Diet-Induced Obese Mice
por: Jung, Un Ju, et al.
Publicado: (2016) -
Obesity, Visceral Fat, and NAFLD: Querying
the Role of Adipokines in the Progression of
Nonalcoholic Fatty Liver Disease
por: Mirza, M. S.
Publicado: (2011) -
Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
por: Roy, Probin Kr, et al.
Publicado: (2023) -
Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
por: Akhtar, Daud H., et al.
Publicado: (2019) -
Maternal adipokines and insulin as biomarkers of pregnancies complicated by overweight and obesity
por: Vernini, Joice Monaliza, et al.
Publicado: (2016)